Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2026-03-09

Clinical Trial Update: Trial of Efficacy of the RetroPerc Device [NA]

View source ↗

Summary

The clinical trial evaluating the RetroPerc device for nephrolithiasis (kidney stones) has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • RetroPerc Device

Snippet

Sponsor: The University of Texas Health Science Center, Houston | Conditions: Kidney Stone | NA | Status: WITHDRAWN